Price Alert

Aileron Therapeutics Inc. (ALRN)

NASDAQ: ALRN · Real-Time Price · USD

2.11

0.18 (9.33%)

At close: Jan 10, 2025, 10:00 PM

Aileron Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	5.72M	7.43M	12.87M	17.65M	21.92M	12.04M	17.34M	12.07M	13.17M	7.78M	5.19M	4.84M	7.63M	7.45M	3.6M	7.6M	10.75M	19.28M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	499K	8.94M	16.05M	20.64M	24.75M	30.63M	42.33M	44.63M	48.73M	44.07M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	2.35M	766K	2K	2K	709K	892K	2.19M	n/a	n/a	n/a	24K	24K	24K	24K	24K	24K	24K	21K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	880K	903K	792K	780K	25K	572K	71K	724K	25K	25K	25K	25K	25K	25K	25K	25K	25K	25K
Total Current Assets	6.6M	8.33M	13.66M	18.68M	23.16M	12.76M	18.27M	12.79M	13.95M	17.11M	21.87M	27.05M	33.55M	39.99M	48.18M	54.42M	60.15M	64.32M
Property-Plant & Equipment	1K	1K	1K	1K	2K	6K	19K	29K	39K	52K	110K	154K	196K	238K	280K	321K	355K	326K
Goodwill & Intangibles	48.53M	48.53M	48.53M	85.53M	85.53M	85.53M	85.53M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	50.88M	49.3M	48.53M	85.53M	86.24M	86.43M	101.02M	29K	39K	52K	134K	178K	220K	262K	304K	345K	379K	347K
Total Assets	57.48M	57.63M	62.19M	104.22M	109.4M	99.19M	119.29M	12.82M	13.99M	17.16M	22.01M	27.23M	33.77M	40.26M	48.48M	54.77M	60.53M	64.67M
Account Payables	6.03M	1.15M	911K	1.08M	782K	2.16M	1.19M	484K	136K	458K	1.72M	945K	1.74M	1.02M	1.21M	1.03M	1.02M	560K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.45M	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	48K	n/a	n/a	n/a	n/a	67K	100K	131K	n/a	93K	93K	329K
Other Current Liabilities	7.69M	5.98M	5.75M	73K	2.72M	1.96M	1.92M	1.04M	960K	2.28M	1.21M	2.39M	2.51M	2.33M	2.02M	2.19M	2.33M	1.66M
Total Current Liabilities	7.69M	5.98M	5.75M	5.66M	4.94M	4.53M	4.38M	1.62M	1.2M	2.88M	3.38M	4.54M	5.15M	4.15M	4.51M	4.56M	4.27M	3.07M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	55K
Other Long-Term Liabilities	n/a	n/a	277K	45.01M	116K	46.58M	91.41M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	1.77M	1.77M	2.05M	48.33M	3.44M	3.33M	108.01M	n/a	n/a	458K	1.75M	n/a	1.84M	1.15M	69K	99K	128K	179K
Total Liabilities	9.47M	7.75M	7.8M	53.99M	8.38M	7.86M	112.4M	1.62M	1.2M	2.88M	3.38M	4.54M	5.15M	4.15M	4.58M	4.66M	4.4M	3.25M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	91.46M	n/a	n/a	n/a	33K	67K	100K	131K	162K	192K	221K	601K
Common Stock	131K	108K	108K	108K	107K	103K	91K	91K	91K	91K	91K	91K	91K	91K	91K	91K	90K	90K
Retained Earnings	-363.72M	-356.9M	-351.4M	-310.42M	-304.57M	-295.63M	-288.52M	-281.18M	-279.35M	-277.56M	-272.79M	-268.24M	-261.87M	-253.88M	-245.46M	-238.66M	-231.95M	-226.27M
Comprehensive Income	-44K	-32K	-18K	-26K	-22K	-63K	-63K	n/a	-2K	-10K	-48K	-98K	-101K	-75K	-13K	1K	6K	-7K
Shareholders Equity	48.01M	49.88M	54.39M	50.23M	101.02M	91.33M	6.89M	11.2M	12.79M	14.27M	18.62M	22.7M	28.62M	36.11M	43.9M	50.11M	56.13M	61.42M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	499K	8.94M	16.05M	20.64M	24.75M	30.63M	42.33M	44.63M	48.73M	44.07M